Enrofloxacin, active substance of the veterinary product, belongs to the group of 3rd generation fluoroquinolones and has a wide spectrum of antibacterial action, is active against gram-positive and gram-negative bacteria, including Escherichia coli, Haemophilus spp., Salmonella spp., Klebsiella spp. , Pasteurella multocida, Pseudomonas spp., Bordetella spp., Campylobacter spp., Corynebacterium spp., Staphylococcus spp., Streptococcus spp., Actinobacillus spp., Clostridium spp., Bacteroides spp., Fusobacterium necrophorum and Mycoplasma spp. Bacterial resistance to enrofloxacin develops relatively slowly.
The mechanism of the antimicrobial action of enrofloxacin is to inhibit the activity of the enzyme gyrase, which affects the replication of the DNA helix in the nucleus of the bacterial cell.
Enrofloxacin is well and quickly absorbed from the gastrointestinal tract and penetrates into all organs and tissues of the body. The maximum concentration of the veterinary product in the blood is reached 1-2 hours after the administration of the veterinary product and lasts for 6 hours, and the therapeutic concentration - for 24 hours. It is excreted from the body mainly unchanged in urine and in small quantities in faeces, in poultry - in droppings.
Enrofloxacin 20-TPV, according to the exposure degree, refers to substances of low hazard (hazard class 4 according to GOST 12.1.007-76).